May 12, 2020
Ocular Therapeutix doses first patient in phase 1 testing of OTX-CSI for treatment of dry eye disease
Ocular Therapeutix has dosed the first patient in phase 1 clinical trial of OTX-CSI for the treatment of dry eye…